InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Laporte Kathleen. Officer active across 3 companies, notably 89bio, Inc.. Aggregated, 10 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €314k. Activity tracked since 17 July 2023. The latest transaction was filed on 15 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Kathleen Laporte is a declarant and a director of Precipio, Inc., CERO THERAPEUTICS HOLDINGS, INC. and 89bio, Inc. She has 10 filings in total, and among the sampled recent filings from 2023-07-18 to 2026-01-20, sales total EUR 313978 and the reported transactions are of Attribution nature.